Alcohol's Effect on Other Chronic Liver Diseases

Clinics in Liver Disease

Volumn 16, Issue 4, 2012, Pages 827-837

  Lee, Maximilian ^a   Kowdley, Kris V ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Alcohol; Autoimmune hepatitis; Cirrhosis; Fatty liver disease; Fibrosis; Hemochromatosis; Hepatitis B; Hepatitis C

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; AUTOIMMUNE LIVER DISEASE; CHRONIC LIVER DISEASE; COMORBIDITY; DISEASE SEVERITY; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW;

ALCOHOL DRINKING; AUTOIMMUNE DISEASES; CHRONIC DISEASE; FATTY LIVER; HEMOCHROMATOSIS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER DISEASES; METABOLIC SYNDROME X; RISK FACTORS;

EID: 84867932196     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2012.08.010     Document Type: Review

References (67)

1. Grundy S.M. Metabolic complications of obesity. Endocrine 2000, 13(2):155-165.
2. Hamaguchi M., Kojima T., Takeda N., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143(10):722-728.
3. Diehl A.M., Goodman Z., Ishak K.G. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988, 95(4):1056-1062.
4. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55(7):434-438.
5. Caldwell S.H., Lee V.D., Kleiner D.E., et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol 2009, 8(4):346-352.
6. Arteel G.E. Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH?. Hepatology 2012, 55(6):2030-2032.
7. Chitturi S., Farrell G.C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001, 21(1):27-41.
8. Gabele E., Dostert K., Dorn C., et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcohol Clin Exp Res 2011, 35(7):1361-1367.
9. Wang Y., Seitz H.K., Wang X.D. Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcohol Clin Exp Res 2010, 34(3):567-573.
10. Ekstedt M., Franzen L.E., Holmqvist M., et al. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 2009, 44(3):366-374.
11. Alkerwi A., Boutsen M., Vaillant M., et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis 2009, 204(2):624-635.
12. Thun M.J., Peto R., Lopez A.D., et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997, 337(24):1705-1714.
13. Sozio M.S., Chalasani N., Liangpunsakul S. What advice should be given to patients with NAFLD about the consumption of alcohol?. Nat Clin Pract Gastroenterol Hepatol 2009, 6(1):18-19.
14. Cotrim H.P., Freitas L.A., Alves E., et al. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur J Gastroenterol Hepatol 2009, 21(9):969-972.
15. Moriya A., Iwasaki Y., Ohguchi S., et al. Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011, 33(3):378-388.
16. Gunji T., Matsuhashi N., Sato H., et al. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 2009, 104(9):2189-2195.
17. Hiramine Y., Imamura Y., Uto H., et al. Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol 2011, 46(4):519-528.
18. Hamaguchi M., Kojima T., Ohbora A., et al. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012, 18(2):156-167.
19. Baker S.S., Baker R.D., Liu W., et al. Role of alcohol metabolism in non-alcoholic steatohepatitis. PloS One 2010, 5(3):e9570.
20. Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006, 144(10):705-714.
21. Davis G.L., Alter M.J., El-Serag H., et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010, 138(2):513-521. e511-6.
22. Thein H.H., Yi Q., Dore G.J., et al. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 2008, 48(2):418-431.
23. Zhang T., Li Y., Lai J.P., et al. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003, 38(1):57-65.
24. Kim W.H., Hong F., Jaruga B., et al. Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. FASEB J 2001, 15(13):2551-2553.
25. Pianko S., Patella S., Ostapowicz G., et al. Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J Viral Hepat 2001, 8(6):406-413.
26. Colell A., Garcia-Ruiz C., Miranda M., et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998, 115(6):1541-1551.
27. Piccoli C., Quarato G., Ripoli M., et al. HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim Biophys Acta 2009, 1787(5):539-546.
28. Thoren F., Romero A., Lindh M., et al. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 2004, 76(6):1180-1186.
29. Miura K., Taura K., Kodama Y., et al. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008, 48(5):1420-1429.
30. Otani K., Korenaga M., Beard M.R., et al. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005, 128(1):96-107.
31. Perlemuter G., Letteron P., Carnot F., et al. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 2003, 39(6):1020-1027.
32. Rigamonti C., Mottaran E., Reale E., et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003, 38(1):42-49.
33. Szabo G., Wands J.R., Eken A., et al. Alcohol and hepatitis C virus: interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res 2010, 34(10):1675-1686.
34. Ye L., Wang S., Wang X., et al. Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes. Drug Alcohol Depend 2010, 112(1-2):107-116.
35. Encke J., Wands J.R. Ethanol inhibition: the humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization. Alcohol Clin Exp Res 2000, 24(7):1063-1069.
36. Takahashi K., Takahashi T., Takahashi S., et al. Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients. J Gastroenterol Hepatol 2001, 16(4):416-423.
37. Wiley T.E., McCarthy M., Breidi L., et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998, 28(3):805-809.
38. Ostapowicz G., Watson K.J., Locarnini S.A., et al. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998, 27(6):1730-1735.
39. Westin J., Lagging L.M., Spak F., et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 2002, 9(3):235-241.
40. Monto A., Patel K., Bostrom A., et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004, 39(3):826-834.
41. Hutchinson S.J., Bird S.M., Goldberg D.J. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005, 3(11):1150-1159.
42. Poynard T., Mathurin P., Lai C.L., et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003, 38(3):257-265.
43. Marcellin P., Pequignot F., Delarocque-Astagneau E., et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008, 48(2):200-207.
44. Mueller S., Millonig G., Seitz H.K. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 2009, 15(28):3462-3471.
45. Machida K., Tsukamoto H., Mkrtchyan H., et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci U S A 2009, 106(5):1548-1553.
46. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11(2):97-107.
47. Larkin J., Clayton M.M., Liu J., et al. Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice. Hepatology 2001, 34(4 Pt 1):792-797.
48. Kim W.H., Hong F., Jaruga B., et al. Hepatitis B virus X protein sensitizes primary mouse hepatocytes to ethanol- and TNF-alpha-induced apoptosis by a caspase-3-dependent mechanism. Cell Mol Immunol 2005, 2(1):40-48.
49. Nomura H., Kashiwagi S., Hayashi J., et al. An epidemiologic study of effects of alcohol in the liver in hepatitis B surface antigen carriers. Am J Epidemiol 1988, 128(2):277-284.
50. Nomura H., Hayashi J., Kajiyama W., et al. Alcohol consumption and seroconversion from hepatitis B e antigen in the Okinawa Japanese. Fukuoka Igaku Zasshi 1996, 87(11):237-241.
51. Gelatti U., Donato F., Tagger A., et al. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol 2003, 98(4):907-914.
52. Wang L.Y., You S.L., Lu S.N., et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003, 14(3):241-250.
53. Jee S.H., Ohrr H., Sull J.W., et al. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004, 96(24):1851-1856.
54. Donato F., Tagger A., Gelatti U., et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002, 155(4):323-331.
55. Zhu G.T., Lou G.Q., Shi J.P. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2011, 25(5):328-330. [in Chinese].
56. Ikeda K., Saitoh S., Suzuki Y., et al. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study. Cancer 1998, 82(5):827-835.
57. Siddique A., Kowdley K.V. Review article: the iron overload syndromes. Aliment Pharmacol Ther 2012, 35(8):876-893.
58. Nieto N., Friedman S.L., Cederbaum A.I. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 2002, 35(1):62-73.
59. Suzuki Y., Saito H., Suzuki M., et al. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res 2002, 26(Suppl 8):26S-31S.
60. Harrison-Findik D.D. Gender-related variations in iron metabolism and liver diseases. World J Hepatol 2010, 2(8):302-310.
61. Valerio L.G., Parks T., Petersen D.R. Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury. Alcohol Clin Exp Res 1996, 20(8):1352-1361.
62. Adams P.C., Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996, 23(4):724-727.
63. Scotet V., Merour M.C., Mercier A.Y., et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol 2003, 158(2):129-134.
64. Fletcher L.M., Dixon J.L., Purdie D.M., et al. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002, 122(2):281-289.
65. Wood M.J., Powell L.W., Dixon J.L., et al. Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus. Hepatology 2012 Mar 15, [Epub ahead of print]. 10.1002/hep.25720.
66. Thiele G.M., Duryee M.J., Willis M.S., et al. Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res 2010, 34(12):2126-2136.
67. Sorrentino P., Terracciano L., D'Angelo S., et al. Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis. J Gastroenterol 2010, 45(10):1053-1062.